Coverage of Cancer Care through Medicare Part B
Hospital Inpatient Care
Medicare National Coverage Determinations
Medicare Part D Prescription Drug Plans
Payment for Anticancer Drugs in Hospital Outpatient Prospective Payment System
Reimbursement for Cancer Care Through Medicare Part B
Reimbursement for Oral Anticancer Therapies
Reimbursement for Anticancer Drugs in Hospital Outpatient Prospective Payment System
Reimbursement for Injectable Drugs
Other

Coverage of Cancer Care through Medicare Part B

• CLC Comments on Compendia for Listing of Off-Label Uses of Cancer Drugs
  (February 27, 2006)
  

Hospital Inpatient Care

• Letter to CMS Administrator Scully Urging Assignment of High-Dose IL-2 Therapy to New DRG
  (September 12, 2002)

Medicare National Coverage Determinations

• CLC Submits Comments on Medicare Coverage Proposal for Erthyropoiesis Stimulating Agents
  (June 13, 2007)

• CLC Comments on CMS Proposal on Coverage with Evidence Development
  (June 6, 2005)

• CLC Comments on Medicare Coverage of Anti-Emetics
  (February 3, 2005)

• CLC Applauds Medicare Coverage of Smoking Cessation Counseling
  (January 21, 2005)

• CLC Urges Broad Coverage of Colorectal Cancer and Other Anti-Cancer Drugs
  (December 23, 2004)
  

• CLC Commends CMS Decision to Expand Coverage of PET Scans
  (December 1, 2004)

• CLC Urges CMS to Abandon National Coverage Analysis Process for Cancer Drugs
  (March 14, 2003)
  
  
• CLC Comments on Proposed Coverage Criteria
  (July 17, 2000)

Medicare Part D Prescription Drug Plans

• CLC Recommends Standards for Coverage of Anticancer Drugs in CY 2007
  (March 6, 2006)
  
  
• CLC Recommends Changes in USP Draft Guidelines for Medicare Plans in 2007
  (January 6, 2006)

• CLC Submits Comments on USP Draft Guidelines for Medicare Part D
  (September 17, 2004)
  

Payment for Anticancer Drugs in Hospital Outpatient Prospective Payment System

• CLC Comments on CY 2007 Proposal for Reimbursing Cancer Therapies in Hospital Outpatient Departments

Reimbursement for Cancer Care Through Medicare Part B

• CLC Urges Changes in Competitive Acquisition Program
  (September 6, 2005)

• CLC Comments on Medicare Coverage of Anti-Emetics
  (February 3, 2005)
  

• CLC Comments on CY 2005 Physician Fee Schedule
  (December 23, 2004)
  

• CLC Urges Prompt Release by CMS of Medicare ASP Data
  (July 7, 2004)

• CLC Submits Comments on Proposed Rule on Payment Reform for Part B Drugs
  (October 10, 2003)
  
  
• Letter to Representatives and Senators Identifying Flaws in Cancer Care Provisions of Medicare Bills
  (July 14, 2003)
  
  
• Letter to Energy & Commerce Committee In Support of Balanced Cancer Care Reform
  (June 18, 2003)
  
  
• Cancer Organizations Express Strong Support for Quality Cancer Care Preservation Act
  (April 7, 2003)
  
  
• CLC Urges President Bush to Ensure Fair Medicare Payment for Cancer Care
  (May 23, 2002)
  
  
• Letter to Energy & Commerce, Ways & Means & Finance Committees Re Medicare Reimbursement for Cancer Drugs
  (December 6, 2001)
  
  
• Letter to All Members of Ways & Means, Energy & Commerce and Senate Finance Committee Regarding Medicare Payment for Physician-Administered Drugs
  (October 19, 2001)
  
  
• Letter to President Clinton Regarding Proposal to Reduce Payments for Anticancer Drugs
  (July 14, 2000)

• Letter to Representative Archer and Other Members of Congress Regarding HHS Proposal to Reduce Medicare Payments for Anticancer Drugs
  (June 8, 2000)

• Letter to Secretary Shalala Regarding Proposal to Reduce Payments for Anticancer Drugs
  (June 8, 2000)

Reimbursement for Oral Anticancer Therapies

• CLC Urges Coverage of Off-Label Uses of Cancer Drugs in Medicare Demonstration Project
  (April 26, 2004)

• CLC Calls for Prompt Implementation of Oral Cancer Demonstration Project
  (March 4, 2004)
  
  
• CLC Urges Medicare Conferees to Approve Oral Drug Coverage
  (November 6, 2003)
  
  
• CLC Commends Senator Hatch for Leadership on Medicare Oral Drug Coverage
  (Oct. 23, 2003)
  
  
• Letter To All Medicare Conferees Urging Oral Cancer Drug Transition Benefit
  (September 24, 2003)
  
  
• CLC Hails Introduction of Access to Cancer Therapies Act in 108th Congress
  (March 13, 2003)
  
  
• Roll Call Ad Urging Congressional Action on Access to Cancer Therapies Act (PDF)
  (October 8, 2002)
  
  
• Letter to Entire Senate Endorsing Access to Cancer Therapies Act
  (October 7, 2002)
  
  
• Letter to Entire Senate (Second Session) Urging Support for Access to Cancer Therapies Act
  (February 21, 2002)
  
  
• Letter to Entire House of Representatives (Second Session) Urging Support for Access to Cancer Therapies Act
  (February 21, 2002)
  
  
• Senior Groups Join CLC in Letter to Congress Endorsing the Access to Cancer Therapies Act
  (November 27, 2001)
  
  
• Letter to Entire House of Representatives Urging Cosponsorship of Access to Cancer Therapies Act of 2001
  (September 6, 2001)
  
  
• Letter to Senators Urging CO-Sponsorship of the Access to Cancer Therapies Act, S. 913
  (June 12, 2001)
  
  
• Letter to Senate Co-Sponsors Applauding Introduction of the Access to Cancer Therapies Act, S. 913
  (June 12, 2001)

• Letter to Representative Pryce Applauding Introduction of the Access to Cancer Therapies Act of 2001
  (April 25, 2001)
  

• Letter to House Commerce Committee and Senate Finance Committee Advocating Part B Coverage for Oral Anticancer Agents
  (September 19, 2000)
  

Reimbursement for Anticancer Drugs in Hospital Outpatient Prospective Payment System

• CLC Submits Comments on Proposed Calendar Year 2004 Update of Hospital Outpatient Prospective Payment System (HOPPS)
  (October 6, 2003)
  
  
• CLC Takes Issue with CMS Policy on Medicare Coverage of New Therapies
  (December 16, 2002)
  
  
• Letter to CMS Administrator Scully Urging Changes in Proposed Rule Setting 2003 Outpatient Payment Rates
  (October 8, 2002)
  
  
• CLC Urges Pass-Through Payment for New Cancer Drugs
  (May 31, 2002)
  
  
• CLC Recommends Correction in Payment Rate for Cancer Drugs Used in Hospital Outpatient Setting
  (May 17, 2002)
  
  
• Letter to CMS Regarding Hospital Outpatient Prospective Payment System Pass-Through Payments
  (October 3, 2001)
  
  
• Letter to President Clinton Regarding Potential Reductions in Payments for Drugs in Hospital Outpatient Departments
  (October 19, 2000)

Reimbursement for Injectable Drugs

• Letter to CMS Administrator Scully Re: Program Memorandum on Self-Administered Drugs
  (July 11, 2002)
  
  
• Letter to CMS Administrator Scully Re: Reimbursement for Injectable Drugs
  (August 28, 2001)
  
  
• Letter to Commerce and Ways and Means Committees Supporting Action to Prevent Changes in Payments for Injectable Drugs
  (April 6, 2000)

Other

• CLC Comments on Proposed Rule on Medicare Prescription Drug Program
  (December 8, 2009)

• CLC Urges Senate Action on Health Reform
  (November 18, 2009)

• CLC Endorses S. 1773, Comprehensive Cancer Care Improvement Act
  (October 27, 2009)

• CLC Endorses HR 1844, Comprehensive Cancer Care Improvement Act
  (October 27, 2009)

• CLC Urges Changes in Proposed 2010 Physician Fee Schedule.
  (October 19, 2009)

• CLC Endorses Comprehensive Cancer Care Improvement Act
  (June 27, 2007)

• CLC Endorses McClellan to Head CMS
  (March 5, 2004)

About CLC  |  What's New  |  Policy Issues  |  Participants' Login
Home  |  Sitemap  |  Contact Info

Copyright © 2001-2002 Cancer Leadership Council. All rights reserved.
Please send comments and suggestions to webmaster@cancerleadership.org.